The Leadership Team at Curtana Pharmaceuticals is responsible for setting the strategic direction and overseeing the development of innovative therapeutics targeting cancer stem cells in the central nervous system. Comprised of key executives, including the CEO and Chief Medical Officer, the team drives decision-making around clinical development, regulatory compliance, and toxicology, ensuring that the company's mission to combat glioblastoma and other brain cancers is effectively realized. Through collaboration and expert guidance, the Leadership Team positions Curtana for success in advancing its groundbreaking treatments.
View all